title: What's new in refractory status epilepticus?
authors.affiliation: Medical-Surgical Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, 177 rue de Versailles, 78150, Le Chesnay cedex, France. slegriel@ch-versailles.fr.|INSERM U970 (Team 4), Paris Cardiovascular Research Center, Paris, France. slegriel@ch-versailles.fr.
authors.forename: Stephane
authors.identifier: 0000-0003-4782-6734
authors.initials: S
authors.lastname: Legriel
authors.affiliation: Department of Intensive Care Medicine, CHUV-University Hospital and Faculty of Biology and Medicine, University of Lausanne, 1011, Lausanne, Switzerland.
authors.forename: Mauro
authors.initials: M
authors.lastname: Oddo
authors.affiliation: Virginia Commonwealth University, Medical College of Virginia Campus, 410 N. 12th Street, Richmond, VA, 23298-0533, USA.
authors.forename: Gretchen M
authors.initials: GM
authors.lastname: Brophy
mesh_terms: D000778:Anesthetics, Dissociative / Q000008:administration & dosage; D018686:Anesthetics, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects; D001463:Barbiturates / Q000008:administration & dosage*; D004351:Drug Resistance / Q000187:drug effects; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D006801:Humans; D007649:Ketamine / Q000008:administration & dosage; D008874:Midazolam / Q000008:administration & dosage*; D015742:Propofol / Q000008:administration & dosage* / Q000009:adverse effects; D013226:Status Epilepticus / Q000000981:diagnostic imaging / Q000188:drug therapy*
chemical_list: D000778:Anesthetics, Dissociative; D018686:Anesthetics, Intravenous; D001463:Barbiturates; D007649:Ketamine; D008874:Midazolam; D015742:Propofol